Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2016 /
Mechanisms of immune escape in non-Hodgkin lymphoma

16th - 20th Apr 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.05.16
Views: 1901

Dr Riccardo Dalla-Favera - Columbia University Medical Center, New York, USA

Dr Riccardo Dalla-Favera speaks with ecancertv at AACR 2016 about the processes by which tumours evade immune detection.

By either sequestering cell surface antigens or subverting checkpoint regulators of cell death, tumours are able to persist within a host and encounter no immune resistance.

Dr Dalla-Favera summarises current research in reawakening a patients immune system, and describes the therapeutic possibilities of directed T cell therapy.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation